A Drug Maker Spends Big in Washington to Make Itself Heard
Friday, July 21, 2017 - 05:02
in Mathematics & Economics
Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.